These results confirmed that HOTTIP was involved in Imatinib resistance by regulating EZH2 to inhibit PTEN expression in CML cells (Figure 6(d)). This evidence concerns the gene PTEN and chronic myelogenous leukemia, BCR-ABL1 positive.